Protective effects of trimetazidine on hypoxic cardiac myocytes from the rat

Fundamental and Clinical Pharmacology

Volumn 11, Issue 5, 1997, Pages 427-439

  Fantini, E ^a   Athias, P ^a   Demaison, L ^b   Grynberg, A ^b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b CEMAGREF   (France)

Author keywords

Action potential; Cardiomyocytes; Contraction; Heart cell culture; Normoxia; Rat ventricle; Substrate free hypoxia; Trimetazidine

Indexed keywords

TRIMETAZIDINE;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HEART CELL CULTURE; HEART MUSCLE CELL; HEART VENTRICLE; HYPOXIA; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030850282     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1997.tb00205.x     Document Type: Article

References (54)

1. Astarie-Dequeker C, Joulin Y, Devynek MA. Inhibitory Effect of trimetazidine on thrombin-induced aggregation and calcium entry into human platelets. J Cardiovasc Pharmacol 1994;23:401-7
2. Athias P, Groz B, Klepping J. Determination of the ionic basis of the spontaneous activity of cultured rat heart cells using microinjection technique. Biol Cell 1980;37:183-8
3. Athias P, Grynberg A. Electrophysiological studies on heart cells in culture. In: Pinson A, ed. The Heart Cells in Culture, Vol 1. Boca Raton, FL: CRC Press, 1987;125-58
4. Aussedat J, Ray A, Kay L, Verdys M, Harpey C, Rossi A. Improvement of long-term preservation of isolated arrested rat hearts: beneficial effect of the anti-ischemic agent Trimetazidine. J Cardiovasc Pharmacol 1993;21:128-35
5. Boucher FR, Hearse DJ, Opie LH. Effects of trimetazidine on ischemic contracture in isolated perfused rat hearts. J Cardiovasc Pharmacol 1994;24:45-9
6. Bricaud H, Brottier L, Barat JL, Combe C, Boussens B, Bonnet J. Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy. Cardiovasc Drugs Ther 1990; 4:861-6
7. Brottier L, Barat JL, Combe C, Boussens B, Bonnet J, Bricaud H. Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy. Eur Heart J 1990;11:207-12
8. Canicave JC. Détermination en simple insu contre placebo de la relation dose-activité du Vastarel 20 mg dans l'insuffisance coronaire chronique. Gaz Med Fr 1980;87:5560-3
9. Chevalier A, Demaison L, Grynberg A, Athias P. Influence of the phospholipid polyunsaturated fatty acid composition on some metabolic disorders induced in rat cardiomyocytes by hypoxia and reoxygenation. J Mol Cell Cardiol 1990;22: 1177-86
10. Courtois M, Khatami S, Fantini E, Athias P, Mielle P, Grynberg A. Polyunsaturated fatty acids in cultured cardiomyocytes: effect on physiology and β-adrenoceptor function. Am J Physiol 1992;262:H451-6
11. D'Alché P, Clauser P, Morel M, Gauthier V. Assessment with potential mapping of the cardiac protective effect of a drug. Example of trimetazidine. J Pharmacol Methods 1991;26: 43-51
12. Dagnelie P. Théories et méthodes statistiques, Vol 2. Gembloux, Belgium: Presses Agronomiques de Gembloux, 1975
13. Dalla-Volta S, Maraglino G, Della-Valentina P, Viena P, Desideri A. Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study. Cardiovasc Drug Ther 1990;4:853-60
14. De la Chapelle-Groz B, Athias P. Gentamicin causes fast depression of action potential and contraction in cultured cardiocytes. Eur J Pharmacol 1988;152:111-20
15. De Leiris J, Boucher F. Rationale for trimetazidine administration in myocardial isehemia-reperfusion syndrome. Eur Heart J 1993;14-SG:34-40
16. Demaison L, Fantini E, Sentex E, Grynberg A, Athias P. Trimetazidine: in vitro influence on heart mitochondrial function. Am J Cardiol 1995;76:31B-7B
17. Detry JM, Sellier P, Pennaforte S, Cokkinos D, Dargie H, Mathes P. Trimetazidine - a new concept in the treatment of angina - comparison with propranolol in patients with stable angina. Br J Clin Pharmacol 1994;37:279-88
18. Devynck MA, Sang KHLQ, Joulin Y, Mazeaud M. Acute membrane effects of trimetazidine in human platelets. Eur J Pharmacol 1993;245:105-10
19. Fabiani JN, Ponzio O, Emerit I, Massonet-Castel S, Paris M, Chevalier P et al. Cardioprotective effect of trimetazidine during coronary artery graft surgery. J Cardiovasc Surg 1992;33:486-91
20. Fantini E, Athias F, Courtois M, Grynberg A. A simple gas-flow chamber for cultured cell electrophysiology in a controlled atmosphere. Pflugers Arch Eur J Physiol 1987;409: 632-4
21. Fantini E, Athias P, Courtois M, Khatami S, Grynberg A, Degois M. Oxygen and substrate deprivation on isolated rat cardiac myocytes: temporal relationship between electromechanical and biochemical consequences. Can J Physiol Pharmacol 1990;68:1148-56
22. Fantini E, Demaison L, Sentex E, Grynberg A, Athias P. Some biochemical aspects of the protective effect of trimetazidine on rat myocytes during hypoxia and reoxygenation. J Mol Cell Cardiol 1994;26:949-58
23. Fermini B, Schanne O. Determinants of action potential duration in neonatal rat ventricle cells. Cardiovasc Res 1991; 25:235-43
24. Findlay I. Physiology and pharmacology of cardiac ATP-sensitive potassium channels. J Cardiovasc Pharmacol 1994; 24:S4
25. Fitoussi M, Rochette L, Bralet J, Harpey C. Incidences fonctionnelles et métaboliques d'un prétraitement par la trimetazidine au niveau du coeur de rat. Arch Mal Coeur Vaiss 1985;78:460
26. Frumin H, Kerin NZ, Rubenfire M. Classification of antiarrhythmic drugs. J Clin Pharmacol 1989;29:387-94
27. Gettes LS. Effect of acute ischemia on cardiac electrophysiology. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. Scientific Fundations, Vol 2. New York: Raven Press, 1986;1317-41
28. Grynberg A, Athias P, Degois M. Effect of change in growth environment on cultured myocardial cells investigated in a standardized medium. In Vitro Cell Dev Biol 1986;22: 44-50
29. Grynberg A, Fantini E, Athias P, Degois M, Guenot L, Courtois M, Khatami S. Modifications of the n6/n-3 fatty acid ratio in the phospholipids of rat ventricular myocytes in culture by the use of synthetic media: functional and biochemical consequences in normoxic and hypoxic conditions. J Mol Cell Cardiol 1988;20:863-74
30. Guarnieri C, Muscari C. Effect of trimetazidine on mitochondrial function and oxidative damage during reperfusion of hypertrophied rat myocardium. Pharmacology 1993;46: 324-31
31. +-ATPaSe activity, and overdrive hyperpolarization in guinea-pig ventricular muscles. Eur J Pharmacol 1991;195:381-8
32. Honoré E, Adamantidis MM, Challice CE, Dupuis BA. Cardioprotection by calcium antagonists, piridoxilate and trimetazidine. IRCS Med Sci 1986;14:938-9
33. Hugtenburg JG, Jap TJW, Mathy MJ, Van Heiningen PNM, Bohnenn VA, Heijnis JB et al. Cardioprotective effect of trimetazidine and nifedipine in guinea-pig hearts subjected to ischaemia. Arch Int Pharmacodyn Ther 1989;300: 186-208
34. Isenberg G, Benndorf K. Action potential and membrane currents during metabolic inhibition. In: Vereeke J, Van Bogaert PP, Verdonck F, eds. Ionic Currents and Ischemia. Leuven: Leuven University Press, 1990;77-91
35. Kiyosue T, Nakamura S, Arita M. Effects of trimetazidine on action potentials and membrane currents of guinea-pig ventricular myocytes. J Mol Cell Cardiol 1986;18:1301-911
36. Kober G, Buck T, Sievert H, Vallbracht C. Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine. Eur Heart J 1992;13: 1109-15
37. Komori S, Ishii M, Hashimoto K. Antiarrhythmic effects of coronary vasodilatators on canine ventricular arrhythmia model. Jpn J Pharmacol 1985;38:73-82
38. Koning MMG, Krams R, Xiao CS, Van Meegen JR, Bezstarosti K, Lamers JMJ et al. Intracoronary trimetazidine does not improve recovery of regional function in a porcine model of repeated ischemia. Cardiovasc Drugs Ther 1994;7:801-7
39. 31P-NMR spectroscopy in the isolated rat heart. Arch Int Pharmacodyn Ther 1987;286:97-110
40. Libersa C, Honoré E, Adamantidis M, Rouet E, Dupuis B. Antiischemic effect of trimetazidine: enzymatic and electric response in a model of in vitro myocardial ischemia. Cardiovasc Drugs Ther 1990;4:808-9
41. 2+ release in cultured neonatal cardiac myocytes. Insight from subcellular release patterns by confocal microscopy. Circ Res 1994;74:979-90
42. Mimura G, Fukushima S. Clinical studies of antiarrhythmic effect of 1-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride (Vastarel). Med Treat 1985;3:263-8
43. Nagata M, Sugimoto J, Morita M. Comparative studies on the pharmacological actions of antiarrhythmics in isolated guinea-pig atria. Jpn Circ J 1973;37:641-6
44. Noble MIM, Belcher PR, Drake-Holland AJ. Limitation of infarct size by trimetazidine in the rabbit. Am J Cardiol 1995;76:B41-4
45. Papadopoulos CL, Kanonidis IE, Kotridis, PS, Papayannis IL, Savatis SC, Missopouloukokka AI et al. The effect of trimetazidine on reperfusion arrhythmias in acute myocardial infarction. Int J Cardiol 1996;55:137-42
46. Pressler ML. Effects of pCai and pHi on cell-to-cell coupling. Experientia 1987;43:1084-91
47. Reimer KA, Steenbergen C, Jennings, RB. Isolated cardiac myocytes: is their response to injury relevant to our understanding of ischemic injury, in vivo? Lab Invest 1985;53: 369-72
48. Reiser HJ, Sullivan ME. Antiarrhythmic drug therapy: new drugs and changing concepts. Fed Proc 1986;45:2206-12
49. 2+ regulation by trimetazidine during cardiac cell acidosis. Cardiovasc Drugs Ther 1988; 1:677-86
50. Roden DM. Ionic mechanism for prolongation of refractoriness and their proarrhythmic and antiarrhythmic correlates. Am J Cardiol 1996;78-4A:12-6
51. Timour Q, Harpey C, Durr F, Faucon G. Is the antianginal action of trimetazidine independent of hemodynamic changes? Cardiovasc Drugs Ther 1991;5:1043-4
52. Vedrinne JM, Vedrinne C, Bompard D, Lehot JJ, Boissel JP, Champsaur G. Myocardial protection during coronary bypass graft surgery: a randomized, double-blind, placebo-controlled study with trimetazidine. Anesth Analg 1996;82:712-8
53. Watanabe T, Delbridge LM, Bustamante JO, McDonald TF. Heterogeneity of the action potential in isolated rat ventricular myocytes and tissus. Circ Res 1983;52:280-90
54. Williams FM, Tanda K, Kus M, Williams TJ. Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits. J Cardiovasc Pharmacol 1993;22:828-33